Clinical Trial Update: Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis [NA]

View source ↗

Summary

A clinical trial update indicates termination of a study evaluating highly active antiretroviral therapy in patients with primary biliary cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cirrhosis

Snippet

Sponsor: University of Alberta | Conditions: Primary Biliary Cirrhosis | NA | Status: TERMINATED